CA2692364C - Reservoir system comprising a closed membrane - Google Patents

Reservoir system comprising a closed membrane Download PDF

Info

Publication number
CA2692364C
CA2692364C CA2692364A CA2692364A CA2692364C CA 2692364 C CA2692364 C CA 2692364C CA 2692364 A CA2692364 A CA 2692364A CA 2692364 A CA2692364 A CA 2692364A CA 2692364 C CA2692364 C CA 2692364C
Authority
CA
Canada
Prior art keywords
dermal
transdermal therapeutic
therapeutic system
active substance
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2692364A
Other languages
English (en)
French (fr)
Other versions
CA2692364A1 (en
Inventor
Heike Hausner
Sebastian Braun
Heiko Spilgies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Luye Pharma AG
Original Assignee
Acino AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acino AG filed Critical Acino AG
Publication of CA2692364A1 publication Critical patent/CA2692364A1/en
Application granted granted Critical
Publication of CA2692364C publication Critical patent/CA2692364C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A61L15/585—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Materials Engineering (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
CA2692364A 2007-07-04 2008-07-04 Reservoir system comprising a closed membrane Active CA2692364C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007030965 2007-07-04
DE102007030965.3 2007-07-04
PCT/DE2008/001112 WO2009003466A1 (de) 2007-07-04 2008-07-04 Reservoirsystem mit verschlossener membran

Publications (2)

Publication Number Publication Date
CA2692364A1 CA2692364A1 (en) 2009-01-08
CA2692364C true CA2692364C (en) 2015-05-19

Family

ID=39878453

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2692364A Active CA2692364C (en) 2007-07-04 2008-07-04 Reservoir system comprising a closed membrane

Country Status (9)

Country Link
US (1) US8440222B2 (enExample)
EP (1) EP2173330B1 (enExample)
JP (1) JP5588864B2 (enExample)
AT (1) ATE551994T1 (enExample)
CA (1) CA2692364C (enExample)
DE (1) DE112008002414A5 (enExample)
ES (1) ES2385231T3 (enExample)
PL (1) PL2173330T3 (enExample)
WO (1) WO2009003466A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11039615B2 (en) * 2014-04-18 2021-06-22 Entrotech Life Sciences, Inc. Methods of processing chlorhexidine-containing polymerizable compositions and antimicrobial articles formed thereby
PH12018501439B1 (en) * 2016-01-11 2023-07-05 Syqe Medical Ltd Personal vaporizing device
JP2020510086A (ja) 2017-03-24 2020-04-02 イー インク カリフォルニア， エルエルシー 活性分子を送達するためのマイクロセルシステム
CN110446491A (zh) 2017-03-24 2019-11-12 伊英克加利福尼亚有限责任公司 调节活性物质给予速率的包含带电粒子或磁性粒子的微单元递送系统
JP6972334B2 (ja) 2017-11-14 2021-11-24 イー インク カリフォルニア， エルエルシー 多孔性伝導電極層を含む電気泳動活性分子送達システム
DE102018216244A1 (de) * 2018-09-24 2020-03-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Barriereschicht
CN110403921A (zh) * 2019-08-29 2019-11-05 上海迦瑞生物医药有限公司 一种卡巴拉汀外用贴剂及其制备方法
WO2021108210A1 (en) 2019-11-27 2021-06-03 E Ink California, Llc Benefit agent delivery system comprising microcells having an electrically eroding sealing layer
WO2022093541A1 (en) 2020-10-29 2022-05-05 E Ink California, Llc Microcell systems for delivering benefit agents
WO2022093547A1 (en) 2020-10-29 2022-05-05 E Ink California, Llc Microcell systems for delivering hydrophilic active molecules

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4382886A (en) * 1981-04-13 1983-05-10 Sosnowski Zenon M Method for extracting propolis and water soluble dry propolis powder
DE3786998D1 (de) 1986-11-20 1993-09-16 Ciba Geigy Ag Benutzer-aktivierte therapeutische systeme.
US4943435A (en) 1987-10-05 1990-07-24 Pharmetrix Corporation Prolonged activity nicotine patch
JP3240496B2 (ja) * 1993-09-30 2001-12-17 タキロン株式会社 経皮吸収製剤
CA2315890C (en) * 1997-12-22 2009-08-11 Alza Corporation Rate controlling membranes for controlled drug delivery devices
US20020182260A1 (en) * 1998-05-29 2002-12-05 Cellegy Pharmaceuticals, Inc. Anti-inflammatory agents and methods for their preparation and use
JP4271869B2 (ja) * 1999-02-09 2009-06-03 サムヤン コーポレイション 経皮投与用抗嘔吐剤組成物およびこれを含む製剤
ES2244422T3 (es) * 1999-04-01 2005-12-16 Alza Corporation Dispositivos para la administracion transdermica de farmacos que comprenden un deposito de poliuretano para farmacos.
DE10137162A1 (de) * 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
AU2002329763B2 (en) * 2001-08-17 2007-11-08 Lavipharm Laboratories Inc. Composition and transdermal drug delivery device
GB0313999D0 (en) 2003-06-17 2003-07-23 Richards Peter W Anti pyrexia patch
WO2007112287A2 (en) * 2006-03-24 2007-10-04 Auxilium Pharmaceuticals, Inc. Hme transdermal compositions containing testosterone

Also Published As

Publication number Publication date
CA2692364A1 (en) 2009-01-08
US8440222B2 (en) 2013-05-14
DE112008002414A5 (de) 2010-06-10
EP2173330A1 (de) 2010-04-14
ATE551994T1 (de) 2012-04-15
WO2009003466A1 (de) 2009-01-08
JP5588864B2 (ja) 2014-09-10
EP2173330B1 (de) 2012-04-04
PL2173330T3 (pl) 2012-08-31
ES2385231T3 (es) 2012-07-19
US20100172959A1 (en) 2010-07-08
JP2010531684A (ja) 2010-09-30

Similar Documents

Publication Publication Date Title
US8440222B2 (en) Reservoir system with closed membrane
US5683711A (en) Active ingredient patch
ES2361068T3 (es) Sistemas analgésicos transdérmicos con potencial de abuso reducido.
DK200500030Y4 (da) Transdermalt plaster til indgivelse af fentanyl
KR100895188B1 (ko) 활성성분으로서 펜타닐을 함유하는 경피치료 시스템
US10729686B2 (en) Pharmaceutical compositions
RU2481826C2 (ru) Содержащий донепезил адгезивный препарат и упаковка для него
KR20060120678A (ko) 남용될 가능성이 감소된 경피용 진통제 시스템
HU227814B1 (en) Transdermal device containing polyvinylpyrrolidone as solubility enhancer
KR20120107153A (ko) 펜타닐 경피 패치제
JPH0371406B2 (enExample)
TWI710381B (zh) 經皮吸收製劑
RS61155B1 (sr) Transdermalni terapijski sistem za davanje aktivne supstance
KR20140016293A (ko) 활성제층 및 활성제 변환층을 포함하는 경피 조성물
CA2662499A1 (en) Transdermal drug administration device
DK164257B (da) Transdermalt farmaceutisk praeparat
RU2396946C2 (ru) Фармацевтический препарат абсорбционного типа для чрескожного введения
US6558696B1 (en) Desoxypeganine
RU2432179C2 (ru) Фармацевтический препарат абсорбционного типа для чрезкожного введения
JP2020518553A (ja) ニコチン含有透明経皮吸収治療システム
JP2004529891A (ja) 部分的ドーパミン−ｄ２作用薬の投与用の経皮治療吸収システム
JPS6321647B2 (enExample)
HK1187247B (en) Transdermal therapeutic system for administering an active substance
HK1187247A (en) Transdermal therapeutic system for administering an active substance

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130703

H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20250106